Coronavirus

Pharma giant Pfizer has already developed and manufactured ingredients for a COVID-19 vaccine targeting the highly contagious Delta variant.

Can AI create vaccines that work against mutations that haven't happened yet, groups of viruses, and virus too tricky to currently stop?

An equitable door-to-door vaccination campaign might be just what it takes to help the U.S.’s most vulnerable communities fight COVID-19.

A new CRISPR treatment that halted coronavirus transmission in human cells could be the easy-to-distribute COVID-19 drug the world needs.

Using a “chimeric” spike protein, researchers have immunized mice against multiple types of coronaviruses with one shot.

Any revised version of the Moderna COVID-19 vaccine will likely include a smaller dose, reducing side effects and increasing the supply of shots.

A mass vaccination experiment in Brazil suggests that even a moderately effective vaccine can have a dramatic effect if enough people get the shot.

An inhaled nanobody treatment for COVID-19 has shown promise in animal tests and could be a more affordable alternative to monoclonal antibody drugs.

Singapore has provisionally authorized a COVID-19 breath test that measures VOCs to deliver accurate results in just one minute.

An inhaled CRISPR treatment can be easily tweaked to attack a variety of viruses, from the one that causes the flu to the coronavirus behind COVID-19.